Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 67.03 |
| 開市 | 66.59 |
| 買盤 | 67.07 x 400 |
| 賣出價 | 67.11 x 400 |
| 今日波幅 | 66.36 - 67.18 |
| 52 週波幅 | 65.90 - 87.87 |
| 成交量 | |
| 平均成交量 | 7,193,293 |
| 市值 | 83.647B |
| Beta 值 (5 年，每月) | 0.20 |
| 市盈率 (最近 12 個月) | 14.91 |
| 每股盈利 (最近 12 個月) | 4.50 |
| 業績公佈日 | 2024年4月25日 |
| 遠期股息及收益率 | 3.08 (4.59%) |
| 除息日 | 2024年3月14日 |
| 1 年預測目標價 | 83.88 |
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
